Home > Insider Trading > Filing (0000950170-24-110997)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1802255	Guardian Pharmacy Services Inc.	GRDN	Retail-Drug Stores And Proprietary Stores (5912)	200100834

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2037899	Jr J Thomas Salentine	300 Galleria Parkway Se, Suite 800 Atlanta GA 30339		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2024-09-27	35,714	$14.00	35,714	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Class B Common Stock	Acquisiton	2024-09-27	24,400,702	$0.00	24,400,702	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,400,702			No	4	A	Indirect

Footnotes

Represents shares purchased pursuant to a directed share program in connection with the Issuer's initial public offering.
Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.